Impact of Mandatory Infectious Diseases Consultation and Real-time Antimicrobial Stewardship Pharmacist Intervention on Bacteremia Bundle Adherence.

Clicks: 372
ID: 108010
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #9 of 227 articles by views in Open forum infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 227 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The purpose of this study was to evaluate the impact of infectious diseases consultation (IDC) and a real-time antimicrobial stewardship (AMS) review on the management of bacteremia (SAB).This retrospective study included adult inpatients with SAB from January 2016 to December 2018 at 7 hospitals. Outcomes were compared between 3 time periods: before mandatory IDC and AMS review (period 1), after mandatory IDC and before AMS review (period 2), and after mandatory IDC and AMS review (period 3). The primary outcome was bundle adherence, defined as appropriate intravenous antimicrobial therapy, appropriate duration of therapy, appropriate surveillance cultures, echocardiography, and removal of indwelling intravenous catheters, if applicable. Secondary end points included individual bundle components, source control, length of stay (LOS), 30-day bacteremia-related readmission, and in-hospital all-cause mortality.A total of 579 patients met inclusion criteria for analysis. Complete bundle adherence was 65% in period 1 (n = 241/371), 54% in period 2 (n = 47/87), and 76% in period 3 (n = 92/121). Relative to period 3, bundle adherence was significantly lower in period 1 (odds ratio [OR], 0.58; 95% confidence interval [CI], 0.37-0.93;  = .02) and period 2 (OR, 0.37; 95% CI, 0.20-0.67;  = .0009). No difference in bundle adherence was noted between periods 1 and 2. Significant differences were seen in obtaining echocardiography (91% vs 83% vs 100%;  < .001), source control (34% vs 45% vs 45%;  = .04), and hospital LOS (10.5 vs 8.9 vs 12.0 days;  = .01). No differences were noted for readmission or mortality.The addition of AMS pharmacist review to mandatory IDC was associated with significantly improved quality care bundle adherence.
Reference Key
arensman2020impactopen Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Arensman, Kellie;Dela-Pena, Jennifer;Miller, Jessica L;LaChance, Erik;Beganovic, Maya;Anderson, Morgan;Rivelli, Anne;Wieczorkiewicz, Sarah M;
Journal Open forum infectious diseases
Year 2020
DOI
10.1093/ofid/ofaa184
URL
Keywords
staphylococcus aureus bacteremia antimicrobial stewardship bundle adherence

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.